Literature DB >> 15654917

Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies.

F Giorgino1, L Laviola, J W Eriksson.   

Abstract

Adipose tissue is now recognized to have a multitude of functions that are of importance in the regulation of energy balance and substrate metabolism. Different hormones, in particular insulin and catecholamines, govern the storage and utilization of energy in the triglyceride depots. In addition, adipocytes produce several different substances with endocrine or paracrine functions, which regulate the overall energetic homeostasis. With excess energy storage, obesity develops, leading to increased risk for type 2 diabetes and cardiovascular disease. The distribution of body fat appears to be even more important than the total amount of fat. Abdominal and, in particular, visceral adiposity is strongly linked to insulin resistance, type 2 diabetes, hypertension and dyslipidaemia, leading to increased risk of cardiovascular disease. The adverse metabolic impact of visceral fat has been attributed to distinct biological properties of adipocytes in this depot compared with other adipose tissue depots. Indeed, regional variations in the metabolic activity of fat cells have been observed. Furthermore, expression studies aiming at defining the unique biological properties of adipose tissues from distinct anatomical sites have identified depot-related differences in the protein content of fat-produced molecules. In this review we wish to summarize important results from the literature and also some recent data from our own work. The main scope is to describe the biological functions of adipose tissue, and to focus on metabolic, hormonal, and signalling differences between fat depots.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654917     DOI: 10.1111/j.1365-201X.2004.01385.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  55 in total

1.  Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes.

Authors:  Shira Landskroner-Eiger; Jiyoung Park; Davelene Israel; Jeffrey W Pollard; Philipp E Scherer
Journal:  Dev Biol       Date:  2010-06-19       Impact factor: 3.582

2.  Single-cell analysis of insulin-regulated fatty acid uptake in adipocytes.

Authors:  Oleg Varlamov; Romel Somwar; Anda Cornea; Paul Kievit; Kevin L Grove; Charles T Roberts
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-06-22       Impact factor: 4.310

Review 3.  Adipocytes as regulators of energy balance and glucose homeostasis.

Authors:  Evan D Rosen; Bruce M Spiegelman
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 4.  Visfatin: the missing link between intra-abdominal obesity and diabetes?

Authors:  Jaswinder K Sethi; Antonio Vidal-Puig
Journal:  Trends Mol Med       Date:  2005-08       Impact factor: 11.951

5.  Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes.

Authors:  Jaime S Rosa; Stacy R Oliver; Rebecca L Flores; Jerry Ngo; Ginger L Milne; Frank P Zaldivar; Pietro R Galassetti
Journal:  Pediatr Diabetes       Date:  2011-03-28       Impact factor: 4.866

6.  Insulin and insulin resistance.

Authors:  Gisela Wilcox
Journal:  Clin Biochem Rev       Date:  2005-05

Review 7.  Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.

Authors:  John N Fain
Journal:  Mediators Inflamm       Date:  2010-05-23       Impact factor: 4.711

Review 8.  Adipose proteome analysis: focus on mediators of insulin resistance.

Authors:  Xiaoli Chen; Sonja Hess
Journal:  Expert Rev Proteomics       Date:  2008-12       Impact factor: 3.940

Review 9.  A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels.

Authors:  Kirstin A Carswell; Ajay P Belgaumkar; Stephanie A Amiel; Ameet G Patel
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

10.  EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.

Authors:  Patricia O Prada; Eduardo R Ropelle; Rosa H Mourão; Claudio T de Souza; Jose R Pauli; Dennys E Cintra; André Schenka; Silvana A Rocco; Roberto Rittner; Kleber G Franchini; José Vassallo; Lício A Velloso; José B Carvalheira; Mario J A Saad
Journal:  Diabetes       Date:  2009-08-20       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.